| Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis Y Alnefeesi, D Chen-Li, E Krane, MY Jawad, NB Rodrigues, F Ceban, ... Journal of psychiatric research 151, 693-709, 2022 | 133 | 2022 |
| Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research F Ceban, A Leber, MY Jawad, M Yu, LMW Lui, M Subramaniapillai, ... Infectious Diseases 54 (7), 467-477, 2022 | 67 | 2022 |
| The abuse liability of ketamine: a scoping review of preclinical and clinical studies TT Le, IP Cordero, MY Jawad, J Swainson, JD Di Vincenzo, S Jaberi, ... Journal of psychiatric research 151, 476-496, 2022 | 55 | 2022 |
| Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis S Meshkat, Y Alnefeesi, MY Jawad, JD Di Vincenzo, NB Rodrigues, ... Psychiatry research 317, 114857, 2022 | 46 | 2022 |
| Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review Y Alnefeesi, JK Tamura, LMW Lui, MY Jawad, F Ceban, S Ling, F Nasri, ... Neuroscience & Biobehavioral Reviews 131, 192-210, 2021 | 29 | 2021 |
| Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review DH Cooper, R Ramachandra, F Ceban, JD Di Vincenzo, TG Rhee, ... Journal of Psychiatric Research 164, 80-89, 2023 | 28 | 2023 |
| The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis MY Jawad, JD Di Vincenzo, F Ceban, S Jaberi, LMW Lui, ES Gillissie, ... Expert opinion on drug safety 21 (6), 841-852, 2022 | 26 | 2022 |
| The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression MY Jawad, JD Di Vincenzo, S Badulescu, KM Teopiz, A Tabassum, ... Neuropharmacology 223, 109299, 2023 | 25 | 2023 |
| The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia MY Jawad, S Meshkat, A Tabassum, A Mckenzie, JD Di Vincenzo, Z Guo, ... CNS spectrums 28 (5), 541-560, 2023 | 21 | 2023 |
| Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment MA Doyle, S Ling, LMW Lui, P Fragnelli, KM Teopiz, R Ho, ... Expert Opinion on Drug Safety 21 (6), 733-743, 2022 | 19 | 2022 |
| Role of oxytocin in the pathogenesis and modulation of borderline personality disorder: A review MY Jawad, B Ahmad, AM Hashmi Cureus 13 (2), 2021 | 17 | 2021 |
| Olanzapine and samidorphan combination treatment: A systematic review MY Jawad, Y Alnefeesi, LMW Lui, F Ceban, DCJ Chen-Li, K Teopiz, ... Journal of affective disorders 301, 99-106, 2022 | 16 | 2022 |
| Psychological impact of the COVID-19 pandemic in children with autism spectrum disorder-a literature review S Ahmed, A Hanif, I Khaliq, S Ayub, S Saboor, S Shoib, MY Jawad, ... International Journal of Developmental Disabilities 70 (2), 173-183, 2024 | 14 | 2024 |
| Biomarkers of ketamine's antidepressant effect: An umbrella review S Meshkat, RC Ho, B Cao, KM Teopiz, JD Rosenblat, TG Rhee, ... Journal of Affective Disorders 323, 598-606, 2023 | 14 | 2023 |
| Ketamine as potential treatment for postpartum depression: A narrative review. D Chen-Li, LMW Lui, JD Rosenblat, O Lipsitz, KM Teopiz, R Ho, ... Annals of clinical psychiatry: official journal of the American Academy of …, 2022 | 14 | 2022 |
| Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a … GH Le, ES Gillissie, TG Rhee, B Cao, Y Alnefeesi, Z Guo, JD Di Vincenzo, ... Expert Opinion on Investigational Drugs 32 (5), 401-415, 2023 | 13 | 2023 |
| The role of ketamine in the treatment of bipolar depression: a scoping review MY Jawad, S Qasim, M Ni, Z Guo, JD Di Vincenzo, G d’Andrea, ... Brain Sciences 13 (6), 909, 2023 | 12 | 2023 |
| Lumateperone for the treatment of adults with schizophrenia: a systematic review MY Jawad, Y Alnefeesi, F Ceban, LMW Lui, S Jaberi, JD Di Vincenzo, ... Current Psychiatry Reports 24 (8), 359-368, 2022 | 12 | 2022 |
| Mediating role of personality traits in the association between multi-dimensional adverse childhood experiences and depressive symptoms among older adults: a 9-year prospective … Y Li, L Cheng, L Guo, L Zhu, H Zhao, C Zhang, M Shen, Y Liu, MY Jawad, ... Journal of affective disorders 331, 167-174, 2023 | 9 | 2023 |
| Evaluating cognitive function in unaffected relatives of individuals with bipolar disorders: A meta-analysis ES Gillissie, JR Krupski, MY Jawad, LMW Lui, JD Di Vencenzo, ... Journal of Psychiatric Research 152, 289-295, 2022 | 9 | 2022 |
Joshua RosenblatUniversity of TorontoBestätigte E-Mail-Adresse bei utoronto.ca
